サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1446449

血管イメージングの市場規模、シェア、動向分析レポート：モダリティ別、エンドユース別、地域別、セグメント予測、2024年～2030年

Vascular Imaging Market Size, Share & Trends Analysis Report By Modality (CT, MRI, Ultrasound, Nuclear Medicine), By End-Use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 105 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血管イメージングの市場規模、シェア、動向分析レポート：モダリティ別、エンドユース別、地域別、セグメント予測、2024年～2030年
出版日: 2024年02月01日
発行: Grand View Research
ページ情報: 英文 105 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血管イメージング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血管イメージング市場規模は、2024年から2030年にかけてCAGR 4.19％を記録し、2030年には85億2,000万米ドルに達する見込みです。

心血管障害の有病率の増加と血管スキャン装置の技術進歩の高まりが、血管イメージング市場を大きく牽引しています。さらに、血管イメージング装置の開発に対する資金調達の増加は、市場をさらに活性化すると予測されています。

3D可視化やハンドヘルド機器を含む超音波技術の最近の開拓は、血管イメージング市場の成長に貢献すると期待されています。2D技術から3Dへの置き換えにより、リアルタイムでトランスデューサを動かすことなく画像を3Dキャプチャできるようになりました。さらに、平面波イメージングに基づくベクトル・ドップラー技術の開発が人気を集めています。この方式は、画像の焦点合わせに必要なフレームレートを効果的に低下させ（スキャンラインを減少させ）、より迅速に行うことができます。

患者数の増加による画像診断センターの増加は、メーカーがより効率的な画像技術を導入する好機です。X線ベースの分析や超音波技術などのイメージング技術の開発が進むことで、血管イメージングの用途が拡大すると予想されます。これらのモダリティは、優れたヘルスケアのために、緩和ケアと治療ケアの両方で非常に好まれています。

血管画像市場レポートハイライト

  • タイプ別では、非侵襲性分野が2023年に血管イメージング市場で最大のシェアを占めたが、これは患者の安全性や所要時間の短縮など、さまざまな手法が提供するさまざまな利点によるものです。
  • CTスキャナは、空間的・時間的解像度の向上、迅速な手技、X線管による異なる角度からの複数画像の提供などの利点があり、このモダリティの用途拡大が期待されています。
  • 2023年の血管画像市場は北米が支配的であったが、これは老年人口における心血管障害の有病率の高さと、ヘルスケア施設の充実によるものでした。
  • アジア太平洋地域の血管画像市場は、中低所得国におけるCVDの高い有病率により、予測期間中に有利な成長率を示すと予想されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血管画像診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 血管画像市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 価格分析

第4章 血管イメージング市場：モダリティの推定・動向分析

  • モダリティ市場シェア、2023年と2030年
  • セグメントダッシュボード
  • モダリティ別の世界の血管画像診断市場の展望
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 血管イメージング市場：最終用途の推定・動向分析

  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の世界の血管画像市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 血管イメージング市場：地域推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 市場規模と予測トレンド分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Siemens Healthineers
    • Abbott Laboratories
    • GE Healthcare
    • Koninklijke Philips NV
    • Hitachi Medical Corporation.
    • Samsung Medison Co., Ltd.
    • Shimadzu Corporation
    • Hologic Inc.
    • Carestream Health Inc.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 6 U.S. vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 Canada vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 11 Europe vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Germany vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 13 Germany vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 15 UK vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 17 France vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 19 Italy vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Spain vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Denmark vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 23 Denmark vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Sweden vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Sweden vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Norway vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 27 Norway vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 31 China vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 32 China vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 34 Japan vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 36 India vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 37 South Korea vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 38 South Korea vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Australia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 40 Australia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Thailand vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 42 Thailand vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Latin America vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Brazil vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 47 Brazil vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Mexico vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 51 Argentina vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 MEA vascular imaging market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 54 MEA vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 55 South Africa vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 56 South Africa vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 60 UAE vascular imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait vascular imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 Kuwait vascular imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Vascular imaging market: market outlook
  • Fig. 14 Vascular imaging competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Vascular imaging market driver impact
  • Fig. 20 Vascular imaging market restraint impact
  • Fig. 21 Vascular imaging market strategic initiatives analysis
  • Fig. 22 Vascular imaging market: Modality movement analysis
  • Fig. 23 vascular imaging market: Modality outlook and key takeaways
  • Fig. 24 CT market estimates and forecast, 2018 - 2030
  • Fig. 25 MRI estimates and forecast, 2018 - 2030
  • Fig. 26 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 27 Nuclear Medicine estimates and forecast, 2018 - 2030
  • Fig. 28 Vascular imaging Market: End-use movement Analysis
  • Fig. 29 vascular imaging market: End use movement analysis
  • Fig. 30 vascular imaging market: End use outlook and key takeaways
  • Fig. 31 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 32 Imaging Centers market estimates and forecasts,2018 - 2030
  • Fig. 33 Others market estimates and forecasts,2018 - 2030
  • Fig. 34 Global vascular imaging market: Regional movement analysis
  • Fig. 35 Global vascular imaging market: Regional outlook and key takeaways
  • Fig. 36 Global vascular imaging market share and leading players
  • Fig. 37 North America market share and leading players
  • Fig. 38 Europe market share and leading players
  • Fig. 39 Asia Pacific market share and leading players
  • Fig. 40 Latin America market share and leading players
  • Fig. 41 Middle East & Africa market share and leading players
  • Fig. 42 North America, by country
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 49 France market estimates and forecasts, 2018 - 2030
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 56 China market estimates and forecasts, 2018 - 2030
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 58 India market estimates and forecasts, 2018 - 2030
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 71 Market share of key market players- vascular imaging market
目次
Product Code: GVR-4-68038-020-0

Vascular Imaging Market Growth & Trends:

The global vascular imaging market size is expected to reach USD 8.52 billion by 2030, registering a CAGR of 4.19% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiovascular disorders and growing technological advancements in vascular scanning devices are majorly driving the vascular imaging market. In addition, growing funding for developments in vascular imaging devices is further anticipated to fuel the market.

Recent developments in ultrasound technology including 3D visualization and handheld devices are expected to contribute to the vascular imaging market growth. Replacement of 2D technology into 3D has enabled 3D capturing of images without the movement of transducer in real-time. In addition, developments in vector-Doppler technique based on plane-wave imaging is gaining popularity. This method effectively decreases the frame rate (reduces scan-lines) required for focusing an image and more rapidly.

Increasing number of diagnostic imaging centers due to increasing patient pool is an opportunity for the manufacturers to introduce more efficient imaging technologies. Increasing developments in imaging technologies, such as X-ray based analyses and ultrasonography techniques are expected to expand the applications of vascular imaging. These modalities are highly preferred in both palliative and curative care for superior levels of healthcare.

Vascular Imaging Market Report Highlights:

  • By type, non-invasive segment held the largest share in vascular imaging market in 2023 owing to various advantages offered by different techniques, such as patient safety and shorter turnaround time
  • Advantages offered by CT scanners, such as enhanced spatial and temporal resolution, quick technique, and offering of multiple images from different angles with the help of x-ray tube are expected to expand the applications of this modality
  • North America dominated the vascular imaging market in 2023, owing to high prevalence of cardiovascular disorders among geriatric population and well-established healthcare facilities
  • Vascular imaging market in Asia Pacific is expected to witness lucrative growth rate over the forecast period owing to high prevalence of CVDs in lower and middle income economies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Vascular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cancer and cardiac diseases
      • 3.2.1.2. Favorable government initiatives
      • 3.2.1.3. Trends of preventive healthcare and disease screening programs
      • 3.2.1.4. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product
      • 3.2.2.2. Increasing use of refurbished products
  • 3.3. Vascular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Vascular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Modality Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Vascular Imaging Market by Modality Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. CT
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. MRI
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Ultrasound
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Nuclear Medicine
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Vascular Imaging Market: End-Use Estimates & Trend Analysis

  • 5.1. End-Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Vascular Imaging Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Imaging Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Vascular Imaging Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Siemens Healthineers
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. GE Healthcare
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Hitachi Medical Corporation.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Samsung Medison Co., Ltd.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Shimadzu Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Hologic Inc.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Carestream Health Inc...
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives